Arkolith/Insider Trading/CRNX/Form 4

Betz Stephen F.

Chief Scientific OfficerCrinetics Pharmaceuticals, Inc. (CRNX) · full profile →Form 4 · filed Dec 29, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 26, 2025Option exercise(M)18K$1.91$34K118K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 26, 2025Option exercise(M)18K—$091K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-25-059009) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML